Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

14
Prescription Drug Summit October 29, 2013 Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 1 Carl Christensen, MD, PhD, FASAM, FACOG Clinical Associate Professor, WSU School of Med Interim Medical Director, Mich Health Prof Recovery Program Medical Director, Tolan Medical Research Clinic Past President, Mich Society Addiction Medicine Pain Recovery Solutions Ann Arbor, MI RECOGNITION AND TREATMENT OF OPIOID DEPENDENCE: What is Addiction and How Do You Treat It? Disclaimers Consultant, PCSS Consultant, DEA/DOJ Consultant, BCBS Speaker, Reckitt Benckiser Former: Methadone provider, WSU Medical Director, Dawn Farm Associate Prof, WSU What is Addiction? What is Addiction? Physiologic Dependence? Lack of willpower? An amoralcondition? A brain disease? Physiology of Addiction 5 Physiologic Dependence: Tolerance and Withdrawal Tolerance: requiring increasing amounts of drug to get the same effect Withdrawal: the opposite effect of the drug when it is removed NEITHER of these imply chemical dependency (addiction) Physiology of Addiction 6 Lack of Willpower? Physiology of Addiction 7

Transcript of Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Page 1: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 1

Carl Christensen, MD, PhD, FASAM, FACOG Clinical Associate Professor, WSU School of Med Interim Medical Director, Mich Health Prof Recovery Program Medical Director, Tolan Medical Research Clinic Past President, Mich Society Addiction Medicine Pain Recovery Solutions Ann Arbor, MI

RECOGNITION AND TREATMENT OF OPIOID DEPENDENCE: What is Addiction and How Do You Treat It?

Disclaimers

n  Consultant, PCSS n  Consultant, DEA/DOJ n  Consultant, BCBS n  Speaker, Reckitt Benckiser

n  Former: ¡  Methadone provider,

WSU ¡  Medical Director, Dawn

Farm ¡  Associate Prof, WSU

What is Addiction? What is Addiction?

n  Physiologic  Dependence?  n  Lack  of  willpower?  n  An  “amoral”  condition?  n  A  brain  disease?  

Physiology of Addiction 5

Physiologic Dependence: Tolerance and Withdrawal

n  Tolerance:    requiring  increasing  amounts  of  drug  to  get  the  same  effect  

n  Withdrawal:    the  opposite  effect  of  the  drug  when  it  is  removed  

n  NEITHER  of  these  imply  chemical  dependency  (addiction)  

Physiology of Addiction 6

Lack of Willpower?

Physiology of Addiction 7

Page 2: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 2

An “amoral” condition?

Physiology of Addiction 8

Brain disease?

Physiology of Addiction 9

The Nucleus Accumbens: GO!!!

Physiology of Addiction 10

VTA: the “gas tank”: supplies dopamine to the Nucleus Accumbens

Physiology of Addiction 11

Frontal Cortex: STOP!!!!

Physiology of Addiction 12

What is the problem?

n  Addiction is not a problem of drug WITHDRAWAL…..

13

Page 3: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 3

What is the problem?

n  Addiction is not a problem of drug WITHDRAWAL…..

n  It is a problem of: ¡  CRAVING ¡  LOSS OF CONTROL ¡  COMPULSIVE USE ¡  USE DESPITE CONSEQUENCES

14

Drug WITHDRAWAL: Gardner 2006

Physiology of Addiction 15

Drug ADDICTION: Gardner 2006

Physiology of Addiction 16

Why Can’t They Stop?????

n  Alcoholics/addicts who finish treatment will often relapse when they re-enter society.

n  They will almost ALWAYS relapse if they undergo quick detox and re-enter society.

n  But: their withdrawal is gone. n  SO: why do they relapse?????

Physiology of Addiction 17

Physiology of Addiction 18

Abnormal response to Ritalin (methylphenidate) is due to abnormal brain chemistry

Physiology of Addiction 22

Page 4: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 4

Physiology of Addiction 24

“I feel like I don’t belong in my own skin….” anonymous alcoholic

n  Decreased  Dopamine  receptors  =decreased  Dopamine  =

n Decreased Hedonic Tone

n  Salsitz 2006

Grand Rounds Hutzel 4 17 07 24 Physiology of Addiction 25

Can you find the (alleged) future alcoholic?

Stimulants & Blood Flow

Physiology of Addiction 27

High flow

Low flow

Healthy Control Cocaine-dependent

Gottschalk, 2001, Am J Psychiatry

Blood Flow Recovery

Physiology of Addiction 28

Non users

Cocaine users, 10 days sober

Cocaine Users, 100 days sober

High blood flow

Low blood flow

How Long to recover

from Methamphetamine?

[C-11]d-threo-methylphenidate

Volkow et al., J. Neuroscience, 2001.

low

high Normal Control

Methamphetamine Abuser (1 month abstinent)

Methamphetamine Abuser (14 months abstinent)

SAFETY OF OPIOIDS IN CHRONIC PAIN MANAGEMENT

34

Page 5: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 5

Are opioids the culprit? Risks factors in opioid deaths in WV HALL et al, JAMA Dec 10 2008; 300; 22: 2613

Risk Factor Percentage involved History of drug abuse 78 Any diverted meds 63 “Nonmedical” route 22 ≥ 5 Providers 21 Alcohol 17 History of previous OD 17 Illicit drug (Coc, H, meth) 16 Currently enrolled in OTP 4 ANY INDICATOR 95 35

Are opioids the culprit? Risks factors in opioid deaths in WV HALL et al, JAMA Dec 10 2008; 300; 22: 2613

Psychotherapeutic Percentage involved ANY PSYCH MED 49 Diazepam 22 Alprazolam (Xanax®) 18 Other benzodiazepine 2 Antidepressant 16 Other psychotherapeutic (AED, ambien)

5

36

4 prescriptions, 4 providers; dead from overdose.

37

The real problem?

38

WHY do doctors over prescribe?

n  The Four D’s: ¡  Dishonest ¡  Dated ¡  Disabled ¡  Duped

39

Russell Portenoy MD

40

Page 6: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 6

Chronic Pain?

43

How to Report…… DISHONEST? n  Allegation Unit n  Bureau of Health Care

Services n  P.O. Box 30454 n  Lansing, 48909 n  (517) 373-9196

DISABLED? n  Michigan Health

Professionals Recovery Program

n  1-800-453-3784 n  WWW.HPRP.ORG

46

How do you recognize when you are fueling addiction rather than treating pain? Making the Diagnosis

47

ADDICTION ↔ PAIN

48

Techniques to Evaluate for signs of addiction in your pain patient

n  Review of Medical Records (refusal?) ◄ n  Physical exam:

¡  Stigmata of addiction: nicotine, opiates, cocaine ¡  Obvious intoxication/withdrawal

n  UDS n  MAPS n  Family interviews n  Multiple visits, evaluate for reliability

51

Urine Drug Screens

n  Check for meds that you have been prescribing. (missing meds = malingering)

n  Check for meds that indicate abuse (MJ, cocaine) = addiction

n  Remember your medication may not show up (methadone, fentanyl, suboxone)

n  TELL THE PATIENT YOU ARE TESTING THEM FOR SAFETY’S SAKE

n  TELL THEM YOU PRACTICE UNIVERSAL SCREENING!

Holy Trinity

53

Page 7: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 7

Reliance on Self Report??

n  Of 400 methadone maintained patients tested with saliva screening who denied recent drug use: ¡  30% were positive for cocaine ¡  14% were positive for heroin

¡  Cone, 2011 59 60

How do you make the diagnosis of addiction?

n  Rule out a pure pain diagnosis ¡  You can have both!!!!

n  Rule out malingering (selling) n  Use the DSM IV/V criteria or the 4 C’s:

n  (Craving, Compulsion, loss of Control & use despite Consequences)

n  Keep asking yourself if you made the right diagnosis

61

Addiction with Secondary Gain (“Drugstore Cowboy”)

62

Addiction with Secondary Gain: Warning Signs

n  Friday afternoon appointments n  Can’t tell you who their referring doc

was n  Just moved from “out of state” n  Vague complaints, normal physical

exam n  Asking for specific narcotics by name n  Most prognostic sign…….

Pregnant?

64 65

“Doctor, am I going to become addicted?”

n  Overall: the incidence of iatrogenic addiction in the chronic pain patient is low.

n  The initial estimate was 1/1000!!! n  BUT:

¡  The incidence of addiction in the chronic pain population is similar to the general population (15%).

n  SO: EXPECT >5% OF YOUR PATIENTS TO SHOW ABERRANT BEHAVIOR

Aronoff, 2000; Heit, 2004; Porter, 1980

Page 8: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 8

What do you do when you realize you are fueling addiction rather than treating pain?

66

ADDICTION ↔ PAIN

Do NOT continue to prescribe!

n  “Impression: ¡  Opioid

dependence”. n  Plan:

¡  “Methadone 10 mg tabs, #240, return one month.”

67

TREATMENT OF ADDICTION

n  Behavioral:    counseling  n  Spiritual:  12  step  meetings  n  Surgical:    gastric  bypass  surgery  n  MEDICAL    n  The  “Gold  Standard”  of  Treatment  

Physiology of Addiction 68

Twelve Step Programs

Physiology of Addiction 69

AA involvement in Veterans 1987, 1988 “Dose Response Curve”

Page 9: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 9

Does 12 step help opioid and cocaine dependence?

Drug No mtgs % < 1 week % > 1 week % Odds Ratio Opiates 38 41 81 6.2* Stimulants 28 52 80 2.9 (NS) Alcohol 25 33 65 9.6*

74

% abstinent, *p ≤0.01 Gossop, 2007

TREATMENT OF ADDICTION: Medical

n  Agonists:    similar  to  the  “drug”  ¡  Suboxone  for  opiate  dependence  ¡  Methadone  for  opiate  dependence  ¡  Nicotine  patches  for  tobacco  dependence  ¡  THC  for  marijuana  dependence  ¡  Dilaudid  for  heroin  dependence!    (Canada)  

Physiology of Addiction 75

TREATMENT OF ADDICTION: Medical

n  Antagonists:    opposite  effect  of  the  drug  ¡  Naltrexone  for  opiate  dependence  

n  Oral:    Rivea  n  Injectable:    Vivitrol  

¡  NOT  A  NARCOTIC  ¡  CANNOT  BE  DIVERTED  

Physiology of Addiction 76

Agonists vs. Antagonists

77

Drug Type Analogy Methadone Full Agonist High Octane Buprenorphine Partial Agonist Low Octane Naltrexone/Naloxone Antagonist Water

BOTTOM LINE:

n  In  both  controlled  and  retrospective  studies,  the  success  rate  for  most  medications  is  between  40  and  60%  (one  to  two  years).  

n  When  patients  come  off  the  medication,  they  relapse.  

n  Relapse  may  be  associated  with  an  increased  chance  of  overdose  and  death.   Physiology of Addiction 78

Benefits of Methadone Salsitz, ASAM, 2012

n  Reduction in death rates (Grondblah, 1990) n  Reduction in IVDU (Ball & Ross, 1991) n  Reduction in # of crime days (Ball & Ross) n  Reduced HIV seroconversion / HCV

conversion n  IMPROVED OUTCOME AFTER

INCARCERATION

Page 10: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 10

Ball 1988: reduction in IVDU

ORT: yes or no??? 80

Ball 1988: reduction in IVDU

ORT: yes or no??? 81

Ball 1988: resumption of IVDU!

ORT: yes or no??? 82

Ball 1988: resumption of IVDU!

ORT: yes or no??? 83

Problems with methadone

n  Requires initial daily dosing first 90 days. n  Must be “clean” for 2 years before you can

dose monthly! n  Methadone clinics may be a source of “wet

faces and wet places” n  Employers will frequently test for methadone

and not employ methadone users, even if they are negative for other drugs.

Problems with methadone: detox

n  Withdrawal from methadone is long lasting and difficult to handle

n  Clients will frequently take months to over one year to detox off methadone

n  Relapse while detoxing off methadone is common

n  Overdose and death may occur if the addict returns to using during this time

Page 11: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 11

Buprenorphine (“Suboxone®/Zubsolv®”)

�  A partial opiate agonist (less potent) ◦  Less analgesic effect ◦  Less respiratory depression ◦  <100 documented deaths in the U.S.

(Soyka); 4000+ PER YEAR WITH METHADONE

◦  Treats both pain and opiate dependency �  Different formulations are approved

Addiction and Pregnancy 87

Buprenorphine long-term follow up: Fiellin, 2008

Concerns about Suboxone

n  It can be abused (mostly for withdrawal)

n  It is unsafe when combined with sedatives & alcohol.

n  It is an opioid. n  Relapse rates after detox exceed

90%. (Weiss, 2011)

89

Vivitrol® (injectable naltrexone) for opioid dependence

Vivitrol: abstinence Vivitrol: craving

Page 12: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 12

Vivitrol: concerns

n  As with methadone and buprenorphine, when the medication is stopped, relapse may lead to death due to lack of tolerance.

n  It is difficult to treat acute pain while on Vivitrol.

The GOLD STANDARD of treatment: 85% success

n  Pilots, Lawyers and Healthcare Prof. n  Continuous monitoring: 3 to 5 years. n  Therapist, Group, 12 step, sponsor n  Immediate intervention for relapse n  Graded response n  Why does it work? IQ?

94

The GOLD STANDARD of treatment: 85% success

n  Hawaii's Opportunity Probation with Enforcement (HOPE) ¡  Continuous monitoring ¡  Treatment / 12 step ¡  Rapid consequences ¡  Graded response

96

Can you detox?

Doc, when can I get off this sh*t?

98

n  101 women underwent detox during pregnancy

n  40 successfully detoxed. n  No adverse fetal effects documented

n  Luty et al, J Sub Abuse Treat 24 (2003); 363 - 367

ORT: yes or no??? 99

Maintenance vs. Detox?

n  40  heroin  addicts  were  started  on  Suboxone.  

n  20  were  “detoxed”  off  and  offered  counseling.  

n  20  were  kept  on  Suboxone  and  offered  counseling.  

n  A  year  later…….  

ORT: yes or no??? 101

Page 13: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 13

102 ORT:

yes or

no???

103 ORT:

yes or

no???

Why Treat Addiction?

111

Drug Dependence, a Chronic Medical Illness: McLellan 2000

112

n  Only about 40% of patients will be abstinent at one year after treatment.

n  Failure rates may be due to lack of aftercare, often due to insurance difficulties

n  Low economic status, psych comorbidity and lack of family/social supports also predict relapse.

n  Relapse is often viewed as “inevitable” and drug dependence as “hopeless”*

Drug Dependence, a Chronic Medical Illness: McLellan 2000

113

n  ONLY 60% OF TYPE I DIABETICS ADHERE TO MEDICATION SCHEDULE

n  LESS THAN 40% OF ASTHMATICS ADHERE TO TREATMENT REGIMEN

n  LESS THAN 40% OF HYPERTENSIVES ADHERE TO THEIR TREATMENT REGIMEN

n  DRUG DEPENDENCE =40 TO 60% ADHERENCE

Addiction: a chronic illness

114

n  If you were to stop taking your insulin, and you wound up in a coma in the ICU, your doctor would say:

n  “you need to go back on insulin! You could have died!”

n  If you were to stop your Suboxone/methadone/12 step treatment, and wind up in the ICU, your doctor would say:

n  “You’re an addict. You’re hopeless!!!!!”

Page 14: Prescription Drug Summit October 29, 2013 RECOGNITION AND ...

Prescription Drug Summit October 29, 2013

Carl Christensen, MD PhD FASAM [email protected] 734 218 5317 14

Chronic, Treatable but Incurable Diseases

n  Obesity  n  Hypertension  n  Diabetes  n  Asthma  n  Addiction        

Physiology of Addiction 115

Contact info: Carl Christensen

n  [email protected]  n  Cell:    734-­‐218-­‐5317  n  Patients:    734  448  0226    

Physiology of Addiction 117